Live from the NIH registry
Studies recruiting near Lake Charles right now
Top 25 of 29 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Accurate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research Inc (SMO/ Network) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Elevara Medicines Limited
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 245 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Sameek Roychowdhury
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Accurate Clinical Research, Inc. | Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Takeda
Study of GS-0151 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 1
Interventional 75 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Gilead Sciences
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 2
Interventional 190 participants sought
Accurate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Zenas BioPharma (USA), LLC
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Vor Biopharma
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Rheumatoid Arthritis
Phase 2
Interventional 160 participants sought
Accurate Clinical Research Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research (SMO/Network/Consortium) /ID# 272650 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AbbVie
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Obesity, Overweight
Phase 3
Interventional 586 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity or Overweight, Type 2 Diabetes Mellitus
Phase 3
Interventional 1,600 participants sought
Elevate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Lake Charles Memorial Hospital — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Stryker Instruments
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Phase 3
Interventional 202 participants sought
Accurate Clinical Research Inc. - Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Care Access-Lake Charles, LA — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: MoonLake Immunotherapeutics AG
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50285 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: UCB Biopharma SRL